• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refining the Classification of Steatotic Liver Disease: Beyond Self-Reported Alcohol Intake.

作者信息

Choi Won-Mook

机构信息

Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Gut Liver. 2025 Sep 15;19(5):639-641. doi: 10.5009/gnl250387.

DOI:10.5009/gnl250387
PMID:40947955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12436052/
Abstract
摘要

相似文献

1
Refining the Classification of Steatotic Liver Disease: Beyond Self-Reported Alcohol Intake.优化脂肪性肝病的分类：超越自我报告的酒精摄入量
Gut Liver. 2025 Sep 15;19(5):639-641. doi: 10.5009/gnl250387.
2
Phosphatidylethanol and self-reported alcohol intake to subclassify in individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study.磷脂酰乙醇和自我报告的酒精摄入量用于对脂肪性肝病风险个体进行亚分类：一项前瞻性队列研究数据分析
Lancet Gastroenterol Hepatol. 2025 Sep 10. doi: 10.1016/S2468-1253(25)00187-6.
3
Nonalcoholic Fatty Liver非酒精性脂肪肝
4
Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis.脂肪性肝病的纵向临床结局与死亡率：一项荟萃分析。
Am J Med. 2025 Apr 30. doi: 10.1016/j.amjmed.2025.04.027.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.代谢功能障碍相关脂肪性肝病、饮酒与心房颤动风险：一项基于全国人口的研究
J Am Heart Assoc. 2025 Jul 15;14(14):e042003. doi: 10.1161/JAHA.125.042003. Epub 2025 Jul 14.
6
Steatotic Liver Disease Classification is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific Treatments.
Clin Gastroenterol Hepatol. 2025 Apr 8. doi: 10.1016/j.cgh.2025.02.007.
7
Phosphatidylethanol in steatotic liver disease.
J Hepatol. 2025 Aug 5. doi: 10.1016/j.jhep.2025.07.019.
8
Colorectal Cancer Incidence in Steatotic Liver Disease (MASLD, MetALD, and ALD).脂肪性肝病（代谢相关脂肪性肝病、代谢性酒精性肝病和酒精性肝病）中的结直肠癌发病率
Clin Gastroenterol Hepatol. 2025 Jan 31. doi: 10.1016/j.cgh.2024.12.018.
9
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake.脂肪性肝病且饮酒过量患者的酒精摄入量量化
JHEP Rep. 2024 Sep 2;7(1):101200. doi: 10.1016/j.jhepr.2024.101200. eCollection 2025 Jan.
10
Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake.代谢功能障碍相关脂肪性肝病患者的肝外事件以及遗传因素和酒精摄入的影响
Hepatol Res. 2025 Jul 1. doi: 10.1111/hepr.14233.

本文引用的文献

1
Misclassification of Alcohol Use Disorder in MASLD and MetALD: Prevalence, Clinical Characteristics, and Outcomes.非酒精性脂肪性肝病和代谢性脂肪性肝病中酒精使用障碍的误诊：患病率、临床特征及转归
Gut Liver. 2025 Jul 25. doi: 10.5009/gnl250072.
2
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
3
MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: A population-based study with 26.7 years of follow-up.伴有任何心血管代谢危险因素个体的代谢相关脂肪性肝病/代谢相关脂肪性肝病与死亡率：一项长达26.7年随访的基于人群的研究。
Hepatology. 2025 Jan 1;81(1):228-237. doi: 10.1097/HEP.0000000000000925. Epub 2024 May 13.
4
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.在疑似代谢相关脂肪性肝病中，酒精性肝病常被误诊，且这种误诊极大地增加了未来发生肝硬化的风险。
Clin Gastroenterol Hepatol. 2024 May;22(5):1048-1057.e2. doi: 10.1016/j.cgh.2024.01.006. Epub 2024 Jan 17.
5
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study.代谢相关脂肪性肝病相关性失代偿期肝硬化患者的病死率：一项全国基于人群的队列研究。
Metabolism. 2024 Mar;152:155789. doi: 10.1016/j.metabol.2024.155789. Epub 2024 Jan 13.
6
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.代谢相关脂肪性肝病与心血管疾病风险。
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
7
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.代谢功能障碍相关脂肪性肝病的批判性评价：两面性现代性的启示。
Clin Mol Hepatol. 2023 Oct;29(4):831-843. doi: 10.3350/cmh.2023.0277. Epub 2023 Aug 25.
8
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
9
Biomarkers of moderate alcohol intake and alcoholic beverages: a systematic literature review.适度饮酒及酒精饮料的生物标志物：一项系统文献综述
Genes Nutr. 2023 Apr 19;18(1):7. doi: 10.1186/s12263-023-00726-1.
10
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.肝脂肪变性指数：一种反映非酒精性脂肪性肝病的简单筛查工具。
Dig Liver Dis. 2010 Jul;42(7):503-8. doi: 10.1016/j.dld.2009.08.002. Epub 2009 Sep 18.